Vivaprime Men 50+
Natural health product licensed in Canada
- Licence holder
- Mission Vivacare Inc.
- NPN or DIN-HM
- 80032779
- Status
- Active licence
- Licence date
- 13 June 2012
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 100 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 100 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide pantothénique Source : D-pantothénate de calcium | 15 mg | 60,000 µg |
| Serenoa repens Source : Fruit lipidosterolic extract Potency : 45 % Fatty acids | 80 mg | Not calculated |
| Bacopa monnieri Source : Plante entière (extrait) Extraction ratio : 8:1 Dry plant equivalent : 100 mg Potency : 20 % Bacosides | 12.5 mg | Not calculated |
| Acide DL-alpha lipoÏque | 25 mg | Not calculated |
| Bêta-carotène Source : Bêta-carotène tout trans Potency : 875 UI | 525 mcg | Not calculated |
| Calcium Source : Ascorbate de calcium | 11.61 mg | 46,440 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxal | 25 mg | 100,000 µg |
| Withania somnifera | 25 mg | Not calculated |
| Ginkgo biloba Source : Extrait de Feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Zinc Source : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH) | 3.75 mg | 15,000 µg |
| Riboflavine | 12.5 mg | 50,000 µg |
| Boron Source : Fructoborate de calcium | 50 mcg | Not calculated |
| Trans-resvératrol Source : Grape skin dry | 2.5 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 18.75 mcg | 75 µg |
| Calcium Source : D-pantothénate de calcium | 2.81 mg | 11,240 µg |
| Lécithine Source : Huile de soja | 6.25 mg | Not calculated |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle Potency : 50 UI | 33.5 mg AT | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 100 UI | 2.5 mcg | 10 µg |
| Ginkgo biloba Source : Extrait de Feuille Potency : 24 % Flavone glycosides | 2.5 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 16.25 mg | 65,000 µg |
Non-medicinal ingredients
Hydroxypropyl methylcellulose, Microcrystalline cellulose, Dioxyde de silicium, Stéarate de magnésium, Croscarmellose de sodium, gomme de guar, propylèneglycol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | minimum: 50 years | 1 Comprimé | 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Vitamin and mineral supplement for the maintenance of good health. An antioxidant for the maintenance of good health. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in the connective tissue formation. Calcium intake, when combined with sufficient vitamin D, a healthy diet and regular exercise, may reduce the risk of developing osteoporosis. Helps to produce red blood cells. Helps to maintain healthy skin. Helps to maintain eyesight, skin, membranes and immune function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80032779
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.